BrdU incorporation revealed a significant decrease in cell proliferation (Figure 3A,B and 4A) and cell cycle analysis exhibited fewer cells in the S-phase of the cell cycle (Figure 3E,F) of Id2-suppressed neuroblastoma cells compared to cells transfected with a control siRNA. The gene discussed is ID2; the disease is neuroblastoma.